您好，欢迎访问山东省农业科学院文献资源数据库平台

Development of Glycosylation-Modified DPPA-1 Compounds as Innovative PD-1/PD-L1 Blockers: Design, Synthesis, and Biological Evaluation

文献类型： 外文期刊

作者： Deng, Peng 1 ; Dong, Xiaodan 1 ; Wu, Ziyuan 2 ; Hou, Xixi 3 ; Mao, Longfei 2 ; Guo, Jingjing 4 ; Zhao, Wenshan 5 ; Peng, Chune 1 ; Zhang, Zhe 6 ; Peng, Lizeng 1 ;

作者机构： 1.Shandong Acad Agr Sci, Inst Agrofood Sci & Technol, Key Lab Novel Food Resources Proc, Shandong Prov Key Lab Agroprod Proc Technol Shando, Jinan 250100, Peoples R China

2.Henan Univ Sci & Technol, Coll Basic Med & Forens Med, 263 Kaiyuan Rd, Luoyang 471023, Peoples R China

3.Henan Normal Univ, Sch Chem & Chem Engn, Xinxiang 453007, Peoples R China

4.Macao Polytech Univ, Fac Appl Sci, Ctr Artificial Intelligence Driven Drug Discovery, Macau 999078, Peoples R China

5.Zhengzhou Univ, Sch Life Sci, Zhengzhou 450001, Peoples R China

6.Henan Univ Technol, Sch Sci, Zhengzhou 450001, Peoples R China

关键词： cancer immunotherapy; immune checkpoint; PD-1/PD-L1; peptide; glycosylation

期刊名称：MOLECULES （ 影响因子：4.6； 五年影响因子：4.9 ）

ISSN：

年卷期： 2024 年 29 卷 8 期

页码：

收录情况： SCI

摘要： In the context of peptide drug development, glycosylation plays a pivotal role. Accordingly, L-type peptides were synthesized predicated upon the PD-1/PD-L1 blocker (D)PPA-1. Subsequent glycosylation resulted in the production of two distinct glycopeptides, D-glu-(L)PPA-1 and D-gal-(L)PPA-1, by using D-glucose (D-glu) and D-galactose (D-gal), respectively, during glycosylation. Both glycopeptides significantly inhibited the interaction between PD-1 and PD-L1, and the measured half maximal inhibitory concentrations (IC50s) were 75.5 mu M and 101.9 mu M for D-glu-LPPA-1 and D-gal-LPPA-1, respectively. Furthermore, D-gal-LPPA-1 displayed a pronounced ability to restore T-cell functionality. In an MC38 tumor-bearing mouse model, D-gal-LPPA-1 demonstrated a significant inhibitory effect. Notably, D-gal-LPPA-1 substantially augmented the abundance and functionality of CD8(+) T cells in the tumor microenvironment. Additionally, in the lymph nodes and spleens, D-gal-LPPA-1 significantly increased the proportion of CD8(+) T cells secreting interferon-gamma (IFN-gamma). These strong findings position D-gal-LPPA-1 as a potent enhancer of the antitumor immune response in MC38 tumor-bearing mice, underscoring its potential as a formidable PD-1/PD-L1 blocking agent.

  • 相关文献
作者其他论文 更多>>
置顶
购物车
反馈

© 京ICP备09089781号-29 主办单位：山东省农业科学院文献资源数据库平台

学术资源： 中国农业科学院 农业专业知识服务系统 农科联盟资源共建共享平台 中国农业科技文献与信息服务平台 中国农业期刊集成服务平台